{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "AstraZeneca agrees to buy majority stake in cancer drug developer Acerta Pharma for $4 billion.", "type_of_material": "News", "word_count": "395", "lead_paragraph": "The deal would be the latest by a pharmaceutical company in what has been a record year for mergers and acquisitions, driven in part by transactions in the health care sector.", "pub_date": "2015-12-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "AstraZeneca to Acquire Majority Stake in Acerta Pharma", "print_headline": "AstraZeneca to Acquire Control of a Cancer Drug Developer"}, "snippet": "The deal would be the latest by a pharmaceutical company in what has been a record year for mergers and acquisitions, driven in part by transactions in the health care sector.", "multimedia": [{"height": 126, "url": "images/2015/12/18/world/18db-Astrazeneca-web/18db-Astrazeneca-web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/18/world/18db-Astrazeneca-web/18db-Astrazeneca-web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 376, "url": "images/2015/12/18/world/18db-Astrazeneca-web/18db-Astrazeneca-web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "376", "xlarge": "images/2015/12/18/world/18db-Astrazeneca-web/18db-Astrazeneca-web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/18/world/18db-Astrazeneca-web/18db-Astrazeneca-web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/18/world/18db-Astrazeneca-web/18db-Astrazeneca-web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/18/business/dealbook/astrazeneca-to-acquire-majority-stake-in-acerta-pharma.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Acerta Pharma BV", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "AstraZeneca PLC", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Great Britain", "name": "glocations"}], "blog": [], "_id": "5672827538f0d82eed76c55e", "source": "The New York Times"}